Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Kaye

Showing results (611-620 of 853) with videos related to

Pageof 86
Sort By:
Cornea|January 26, 2019
Biobanking of Dehydrated Human Donor Corneal Stroma to Increase the Supply of Anterior Lamellar GraftsVito Romano, Hannah J Levis, Paola Gallon, et al.
The Australian and New Zealand Journal of Surgery|June 1, 1985
EORTC Genito-Urinary Group studies in advanced testicular cancer--past and futureS B Kaye, W W Bokkel-Huinink, A T van Oosterom, et al.
ACS Applied Materials & Interfaces|September 19, 2019
Antimicrobial Nitric Oxide Releasing Contact Lens Gels for the Treatment of Microbial KeratitisJenny Aveyard, Robert C Deller, Rebecca Lace, et al.
ACS Materials Au|March 1, 2023
Antimicrobial Nitric Oxide-Releasing Electrospun Dressings for Wound Healing ApplicationsMan Li, Jenny Aveyard, Kyle G Doherty, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Phase I clinical study of LL-D49194 alpha 1 with retrospective pharmacokinetic investigations in mice and humans. The EORTC ECTGJ Cassidy, M A Graham, W Ten Bokkel Huinink, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Phase I study of the anthrapyrazole biantrazole: clinical results and pharmacologyS G Allan, J Cummings, S Evans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1994
Docetaxel (Taxotere): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials GroupG Catimel, J Verweij, V Mattijssen, et al.
Journal of Pharmaceutical and Biomedical Analysis|January 1, 1991
Measurement of the class III antidysrhythmic drug, UK-68,798, in plasma by radioimmunoassayD K Walker, G W Aherne, J E Arrowsmith, et al.
British Journal of Urology|August 1, 1991
Results of Medical Research Council phase II study of low dose cisplatin and methotrexate in the primary treatment of locally advanced (T3 and T4) transitional cell carcinoma of the bladderJ T Roberts, S D Fossa, B Richards, et al.
Communicable Diseases Intelligence Quarterly Report|November 3, 2009
Prevalence of transmitted HIV drug resistance since the availability of highly active antiretroviral therapyJessica S Russell, Doris Chibo, Matthew B Kaye, et al.
Pageof 86

Showing results (611-620 of 853) with videos related to

Sort By:
Pageof 86
Cornea|January 26, 2019
Biobanking of Dehydrated Human Donor Corneal Stroma to Increase the Supply of Anterior Lamellar GraftsVito Romano, Hannah J Levis, Paola Gallon, et al.
The Australian and New Zealand Journal of Surgery|June 1, 1985
EORTC Genito-Urinary Group studies in advanced testicular cancer--past and futureS B Kaye, W W Bokkel-Huinink, A T van Oosterom, et al.
ACS Applied Materials & Interfaces|September 19, 2019
Antimicrobial Nitric Oxide Releasing Contact Lens Gels for the Treatment of Microbial KeratitisJenny Aveyard, Robert C Deller, Rebecca Lace, et al.
ACS Materials Au|March 1, 2023
Antimicrobial Nitric Oxide-Releasing Electrospun Dressings for Wound Healing ApplicationsMan Li, Jenny Aveyard, Kyle G Doherty, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Phase I clinical study of LL-D49194 alpha 1 with retrospective pharmacokinetic investigations in mice and humans. The EORTC ECTGJ Cassidy, M A Graham, W Ten Bokkel Huinink, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Phase I study of the anthrapyrazole biantrazole: clinical results and pharmacologyS G Allan, J Cummings, S Evans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1994
Docetaxel (Taxotere): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials GroupG Catimel, J Verweij, V Mattijssen, et al.
Journal of Pharmaceutical and Biomedical Analysis|January 1, 1991
Measurement of the class III antidysrhythmic drug, UK-68,798, in plasma by radioimmunoassayD K Walker, G W Aherne, J E Arrowsmith, et al.
British Journal of Urology|August 1, 1991
Results of Medical Research Council phase II study of low dose cisplatin and methotrexate in the primary treatment of locally advanced (T3 and T4) transitional cell carcinoma of the bladderJ T Roberts, S D Fossa, B Richards, et al.
Communicable Diseases Intelligence Quarterly Report|November 3, 2009
Prevalence of transmitted HIV drug resistance since the availability of highly active antiretroviral therapyJessica S Russell, Doris Chibo, Matthew B Kaye, et al.
Pageof 86